Introduction
Diabetic ketoacidosis (DKA) is a serious life-threatening complication of diabetes mellitus characterized with high anion gap metabolic acidosis due to excessive production of ketoacids at an expense of reduced serum bicarbonate concentration [1] . Over the past years, the limelight has been on DKA for any diabetic patient but less on hyperchloremic related acidosis. Until recent years, a raised serum chloride concentration was observed to have a clinical impact in renal impairment after administration of large quantities of chloride containing saline solutions hence causing hyperchloremic non-anion gap metabolic acidosis [2, 3] . It results from raised chloride concentrations and bicarbonate loss with a normal anion gap. The identified aetiologies are gastrointestinal causes (diarrhoea), renal tubular acidosis (RTA), and exogenous causes (0.9% normal saline administration) [4] . Here we describe a case of a type 1 diabetic young woman with hyperchloremia and high-anion gap acidosis.
Case presentation
A 20 years old female with type 1 diabetes mellitus on Mixtard in-sulin® 30/70 (fast/intermediate-acting insulin), presented to the emergency department with nausea, vomiting and watery diarrhoea (4 to 6 motions per day) for 3 days duration. She also had occasional spikes of fever and light-headedness. She denied history of syncope, seizures nor had any food or drug allergies.
On arrival vitals were: BP: 104/60 mmHg, HR: 124 bpm, RR: 25 breaths/min, Temp: 36.5°C, SpO2 96% on room air, and random blood glucose: 24 mmol/l.
The physical exam revealed, she was well-nourished but dehydrated weighing about 60 kg. She was lethargic with deep laboured breathing (Kussmaul breathing) and dehydrated. She was alert and oriented to time, place and person. Abdominal exam revealed mild epigastric tenderness on superficial palpation. The rest exams were unremarkable.
Based on her history and clinical findings a diagnosis of DKA due to acute gastroenteritis was made. Two IV access with large-bore cannula were placed and a normal saline bolus of 3.5 l was given with attention to urine output, which was adequate. IV Ciprofloxacin 200 mg, Metoclopramide 10 mg and Rabeprazole 20 mg were also initiated. Thereafter, DKA management protocol was initiated.
Blood samples were taken for CBC, H. pylori antigen test, Malaria slide and Widal tests which were all unremarkable except for Leukocytosis in the CBC. Urine analysis was unremarkable including the absence of ketones. These results were obtained 2 h after her ED presentation except for venous blood gas and electrolytes which were obtained using bedside point-of-care (POC) machine at the ED and ICU whereby she was admitted.
Serial venous blood gases and electrolytes at every 3 to 6 hour interval were done. The initial results were: pH = 6.83 (7.35-7.45), PaCO 2 = 21.9 mmHg (35-45 mmHg) HCO 3 = 3.6 mmol/l (23-28 mmol/l), Na = 143 mmol/l (135-145 mmol/l), K = 6.3 mmol/l (3.5-4.5 mmol/l), Cl = 122 mmol/l (98-109 mmol/l), Creatinine = 60 μmol/l (53-115 μmol/l), Urea = 5.2 mmol/l (2.9-8.4 mmol/l), Anion-gap = 17.4 mmol/l (8-16 mmol/l). The rest were as follows ( Table 1) :
From arrival up to the 2nd hour, the DKA protocol was initiated with insulin infusion at 0.1 U/kg/h and normal saline 500 ml admixed with potassium chloride 20 mmol running at 125 ml/h without the use of sodium bicarbonate infusion.
We acknowledged from the third hour of her treatment that this was not typical of DKA, as there were no clinical improvement nor any significant changes in her blood gas parameters. Thus, the diagnosis changed to hyperchloremic metabolic acidosis with high-anion gap due to acute gastroenteritis and in part, normal saline induced.
Her treatment was modified by adding sodium bicarbonate infusion, whereby HCO 3 deficit was calculated.
a. Sodium bicarbonate 40 mmol plus potassium chloride 20 to 40 mmol admixed in 5% Dextrose water 500 ml bottle ran 125 ml/h. b. Fast acting insulin constant rate at 0.05 U/kg/h (3 U/h).
This treatment plan continued for 48 h and was stopped when pH and chloride concentration started normalising (see Table 1 ) and there was a significant patient improvement. Thereafter she was transferred to the general ward to resume her insulin regime and antibiotics. Later she was discharged and advised her usual diabetic clinic follow-up.
Discussion
Anion gap is referred to as the difference of the measured cations and anions. The normal values are 8-16 mmol/l. Hyperchloremic acidosis is a form of metabolic acidosis associated with a normal anion gap, decrease in plasma bicarbonate concentration, and an increase in plasma chloride concentration [4] . Common causes are large volume of chloride-containing saline administration, following diabetic ketoacidosis, and secondary to diarrhoea in the treatment of hypovolemia or shock. This ultimately leads to reduction in the glomerular filtration rate and then acute kidney injury [5] .
Patients with diarrhoea are usually associated with normal aniongap metabolic acidosis due to the large volume and bicarbonate losses which in-return later may lead to a rise in chloride concentration via the kidneys to maintain metabolic balance leading to high-anion gap [6] , hence hyperchloremic high-anion gap acidosis.
Hyperchloremic acidosis, whether non-anion or high-anion gap, had been under-reported except for one recent study by Toledo et al., describing the prevalence of hyperchloremic high-anion gap acidosis of about 55% during the DKA presentation [7] . On the contrary, our patient had presented with hyperchloremia with high-anion gap acidosis but without urinary ketones.
Bicarbonate therapy has not shown any benefit in acute high-anion gap metabolic acidosis such as diabetic ketoacidosis, lactic acidosis and septic shock [8, 9] . However in hyperchloremic non-anion gap metabolic acidosis, it had shown promising results in the clinical and biochemical improvements [10] . Bicarbonate therapy in hyperchloremic non-anion gap metabolic acidosis has been widely accepted and addressed in the past few years but to our knowledge, very little is known about this therapy in hyperchloremia with high-anion gap.
Conclusion
Many clinicians show a limited focus on chloride anion and its clinical significance. This case and the literature review aims at creating awareness on both, non-anion gap and high-anion gap hyperchloremic metabolic acidosis. We hope to prompt further studies to take place with regards to bicarbonate therapy in a setting of high-anion gap hyperchloremic metabolic acidosis. 
